Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery.

Sharabi-Nov A, Kumar K, Fabjan Vodušek V, Premru Sršen T, Tul N, Fabjan T, Meiri H, Nicolaides KH, Osredkar J.

Fetal Diagn Ther. 2019 Nov 28:1-14. doi: 10.1159/000502177. [Epub ahead of print]

PMID:
31778996
2.

Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response.

Balogh A, Toth E, Romero R, Parej K, Csala D, Szenasi NL, Hajdu I, Juhasz K, Kovacs AF, Meiri H, Hupuczi P, Tarca AL, Hassan SS, Erez O, Zavodszky P, Matko J, Papp Z, Rossi SW, Hahn S, Pallinger E, Than NG.

Front Immunol. 2019 Jun 19;10:1240. doi: 10.3389/fimmu.2019.01240. eCollection 2019.

3.

Galectin 13 (PP13) Facilitates Remodeling and Structural Stabilization of Maternal Vessels during Pregnancy.

Sammar M, Drobnjak T, Mandala M, Gizurarson S, Huppertz B, Meiri H.

Int J Mol Sci. 2019 Jun 29;20(13). pii: E3192. doi: 10.3390/ijms20133192. Review.

4.

Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration.

Drobnjak T, Jónsdóttir AM, Helgadóttir H, Runólfsdóttir MS, Meiri H, Sammar M, Osol G, Mandalà M, Huppertz B, Gizurarson S.

Int J Womens Health. 2019 Mar 27;11:213-222. doi: 10.2147/IJWH.S188303. eCollection 2019.

5.

Aspirin causes endothelium-dependent vasodilation of resistance arteries from non-gravid and gravid rats.

Helgadottir H, Tropea T, Gizurarson S, Meiri H, Mandalà M.

Pregnancy Hypertens. 2019 Jan;15:141-145. doi: 10.1016/j.preghy.2019.01.001. Epub 2019 Jan 10.

6.

Maternal serum screening marker levels in twin pregnancies affected by gestational diabetes.

Maymon R, Meiri H, Svirski R, Weiner E, Cuckle H.

Arch Gynecol Obstet. 2019 Mar;299(3):655-663. doi: 10.1007/s00404-018-5010-3. Epub 2018 Dec 19.

PMID:
30569341
7.

Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Than NG, Romero R, Tarca AL, Kekesi KA, Xu Y, Xu Z, Juhasz K, Bhatti G, Leavitt RJ, Gelencser Z, Palhalmi J, Chung TH, Gyorffy BA, Orosz L, Demeter A, Szecsi A, Hunyadi-Gulyas E, Darula Z, Simor A, Eder K, Szabo S, Topping V, El-Azzamy H, LaJeunesse C, Balogh A, Szalai G, Land S, Torok O, Dong Z, Kovalszky I, Falus A, Meiri H, Draghici S, Hassan SS, Chaiworapongsa T, Krispin M, Knöfler M, Erez O, Burton GJ, Kim CJ, Juhasz G, Papp Z.

Front Immunol. 2018 Aug 8;9:1661. doi: 10.3389/fimmu.2018.01661. eCollection 2018.

8.

Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits.

Drobnjak T, Meiri H, Mandalá M, Huppertz B, Gizurarson S.

Drug Des Devel Ther. 2018 Jul 3;12:1977-1983. doi: 10.2147/DDDT.S167926. eCollection 2018.

9.

Reduced placental protein 13 (PP13) in placental derived syncytiotrophoblast extracellular vesicles in preeclampsia - A novel tool to study the impaired cargo transmission of the placenta to the maternal organs.

Sammar M, Dragovic R, Meiri H, Vatish M, Sharabi-Nov A, Sargent I, Redman C, Tannetta D.

Placenta. 2018 Jun;66:17-25. doi: 10.1016/j.placenta.2018.04.013. Epub 2018 Apr 25.

PMID:
29884298
10.

Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function.

Meiri H, Osol G, Cetin I, Gizurarson S, Huppertz B.

Comput Struct Biotechnol J. 2017 Sep 22;15:433-446. doi: 10.1016/j.csbj.2017.09.002. eCollection 2017. Review.

11.

Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age.

Madar-Shapiro L, Karady I, Trahtenherts A, Syngelaki A, Akolekar R, Poon L, Cohen R, Sharabi-Nov A, Huppertz B, Sammar M, Juhasz K, Than NG, Papp Z, Romero R, Nicolaides KH, Meiri H.

Fetal Diagn Ther. 2018;43(4):250-265. doi: 10.1159/000477933. Epub 2017 Jul 21.

12.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.

Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH.

N Engl J Med. 2017 Aug 17;377(7):613-622. doi: 10.1056/NEJMoa1704559. Epub 2017 Jun 28.

13.

Placental protein 13 (PP13)-induced vasodilation of resistance arteries from pregnant and nonpregnant rats occurs via endothelial-signaling pathways.

Drobnjak T, Gizurarson S, Gokina NI, Meiri H, Mandalá M, Huppertz B, Osol G.

Hypertens Pregnancy. 2017 May;36(2):186-195. doi: 10.1080/10641955.2017.1295052. Epub 2017 May 19.

PMID:
28524718
14.

Eosinophilic funiculitis initially diagnosed as irreducible inguinal hernia: A case report.

Yamada K, Ikubo A, Ikeda S, Koga S, Tsuru Y, Kuroki H, Koya N, Samejima R, Sakai M, Tabuchi M, Yunotani S, Kido S, Nishimura K, Meiri H.

Int J Surg Case Rep. 2017;35:44-48. doi: 10.1016/j.ijscr.2017.03.032. Epub 2017 Apr 5.

15.

Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface.

Sammar M, Siwetz M, Meiri H, Fleming V, Altevogt P, Huppertz B.

Histochem Cell Biol. 2017 May;147(5):565-574. doi: 10.1007/s00418-016-1531-7. Epub 2016 Dec 23.

PMID:
28012129
16.

Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies.

Maymon R, Trahtenherts A, Svirsky R, Melcer Y, Madar-Shapiro L, Klog E, Meiri H, Cuckle H.

Hypertens Pregnancy. 2017 Feb;36(1):108-115. doi: 10.1080/10641955.2016.1242605. Epub 2016 Nov 11.

PMID:
27835040
17.

Can Staining of Damaged Proteins in Urine Effectively Predict Preeclampsia?

Sammar M, Syngelaki A, Sharabi-Nov A, Nicolaides K, Meiri H.

Fetal Diagn Ther. 2017;41(1):23-31. doi: 10.1159/000444450. Epub 2016 Mar 2.

PMID:
26930075
18.

Relationship between first-trimester serum placental protein-13 and maternal characteristics, placental Doppler studies and pregnancy outcome.

Seravalli V, Grimpel YI, Meiri H, Blitzer M, Baschat AA.

J Perinat Med. 2016 Jul 1;44(5):543-9. doi: 10.1515/jpm-2015-0324.

PMID:
26910737
19.

Placental Protein 13 Administration to Pregnant Rats Lowers Blood Pressure and Augments Fetal Growth and Venous Remodeling.

Gizurarson S, Sigurdardottir ER, Meiri H, Huppertz B, Sammar M, Sharabi-Nov A, Mandalá M, Osol G.

Fetal Diagn Ther. 2016;39(1):56-63. doi: 10.1159/000381914. Epub 2015 Aug 28.

20.

Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy.

Than NG, Balogh A, Romero R, Kárpáti E, Erez O, Szilágyi A, Kovalszky I, Sammar M, Gizurarson S, Matkó J, Závodszky P, Papp Z, Meiri H.

Front Immunol. 2014 Aug 20;5:348. doi: 10.3389/fimmu.2014.00348. eCollection 2014. Review.

21.

The role of the carbohydrate recognition domain of placental protein 13 (PP13) in pregnancy evaluated with recombinant PP13 and the DelT221 PP13 variant.

Sammar M, Nisamblatt S, Gonen R, Huppertz B, Gizurarson S, Osol G, Meiri H.

PLoS One. 2014 Jul 31;9(7):e102832. doi: 10.1371/journal.pone.0102832. eCollection 2014. Retraction in: PLoS One. 2019 Jul 25;14(7):e0220517.

22.

Prediction of preeclampsia by placental protein 13 and background risk factors and its prevention by aspirin.

Meiri H, Sammar M, Herzog A, Grimpel YI, Fihaman G, Cohen A, Kivity V, Sharabi-Nov A, Gonen R.

J Perinat Med. 2014 Sep;42(5):591-601. doi: 10.1515/jpm-2013-0298.

PMID:
24607918
23.

First trimester maternal serum placental protein 13 levels in singleton vs. twin pregnancies with and without severe pre-eclampsia.

Svirsky R, Meiri H, Herzog A, Kivity V, Cuckle H, Maymon R.

J Perinat Med. 2013 Sep 1;41(5):561-6. doi: 10.1515/jpm-2013-0011.

PMID:
23729534
24.

Time-lapse electrical recordings of single neurons from the mouse neocortex.

Cohen L, Koffman N, Meiri H, Yarom Y, Lampl I, Mizrahi A.

Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5665-70. doi: 10.1073/pnas.1214434110. Epub 2013 Mar 18.

25.

Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia.

Huppertz B, Meiri H, Gizurarson S, Osol G, Sammar M.

Hum Reprod Update. 2013 Jul-Aug;19(4):391-405. doi: 10.1093/humupd/dmt003. Epub 2013 Feb 17. Review.

PMID:
23420029
26.

Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents.

Gizurarson S, Huppertz B, Osol G, Skarphedinsson JO, Mandala M, Meiri H.

Fetal Diagn Ther. 2013;33(4):257-64. doi: 10.1159/000345964. Epub 2013 Feb 8.

PMID:
23406577
27.

Frontal lobe role in simple arithmetic calculations: an fNIR study.

Meiri H, Sela I, Nesher P, Izzetoglu M, Izzetoglu K, Onaral B, Breznitz Z.

Neurosci Lett. 2012 Feb 21;510(1):43-7. doi: 10.1016/j.neulet.2011.12.066. Epub 2012 Jan 10.

PMID:
22260794
28.

Economic assessment of screening for pre-eclampsia.

Shmueli A, Meiri H, Gonen R.

Prenat Diagn. 2012 Jan;32(1):29-38. doi: 10.1002/pd.2871. Epub 2012 Jan 11.

PMID:
22234821
29.

Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia.

Kliman HJ, Sammar M, Grimpel YI, Lynch SK, Milano KM, Pick E, Bejar J, Arad A, Lee JJ, Meiri H, Gonen R.

Reprod Sci. 2012 Jan;19(1):16-30. doi: 10.1177/1933719111424445. Epub 2011 Oct 11.

PMID:
21989657
30.

Implicit learning processes of compensated dyslexic and skilled adult readers.

Meiri H.

Dev Neuropsychol. 2011;36(7):939-43. doi: 10.1080/87565641.2011.606419.

PMID:
21978014
31.

PP13, maternal ABO blood groups and the risk assessment of pregnancy complications.

Than NG, Romero R, Meiri H, Erez O, Xu Y, Tarquini F, Barna L, Szilagyi A, Ackerman R, Sammar M, Fule T, Karaszi K, Kovalszky I, Dong Z, Kim CJ, Zavodszky P, Papp Z, Gonen R.

PLoS One. 2011;6(7):e21564. doi: 10.1371/journal.pone.0021564. Epub 2011 Jul 25.

32.

Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome.

Balogh A, Pozsgay J, Matkó J, Dong Z, Kim CJ, Várkonyi T, Sammar M, Rigó J Jr, Meiri H, Romero R, Papp Z, Than NG.

Am J Obstet Gynecol. 2011 Aug;205(2):156.e1-14. doi: 10.1016/j.ajog.2011.03.023. Epub 2011 Mar 22.

33.

Similar cation channels mediate protection from cerebellar exitotoxicity by exercise and inheritance.

Ben-Ari S, Ofek K, Barbash S, Meiri H, Kovalev E, Greenberg DS, Soreq H, Shoham S.

J Cell Mol Med. 2012 Mar;16(3):555-68. doi: 10.1111/j.1582-4934.2011.01331.x.

34.

Cryogenic and low temperature preservation of human placental villous explants - a new way to explore drugs in pregnancy disorders.

Huppertz B, Kivity V, Sammar M, Grimpel Y, Leepaz N, Orendi K, Pekarski I, Meiri H, Gonen R, Lubzens E.

Placenta. 2011 Feb;32 Suppl:S65-76. doi: 10.1016/j.placenta.2010.11.020.

PMID:
21257084
35.

Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia.

Orendi K, Kivity V, Sammar M, Grimpel Y, Gonen R, Meiri H, Lubzens E, Huppertz B.

Placenta. 2011 Feb;32 Suppl:S49-54. doi: 10.1016/j.placenta.2010.11.023. Review.

PMID:
21257083
36.

Placenta-bound and body fluid PP13 and its mRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery.

Sammar M, Nisemblat S, Fleischfarb Z, Golan A, Sadan O, Meiri H, Huppertz B, Gonen R.

Placenta. 2011 Feb;32 Suppl:S30-6. doi: 10.1016/j.placenta.2010.09.006.

PMID:
21257080
37.

Development of early non-invasive markers and means for the diagnosis and progression monitoring of preeclampsia and tailoring putative therapies (project pregenesys 037244).

Meiri H, Huppertz B, Cetin I.

Placenta. 2011 Feb;32 Suppl:S1-3. doi: 10.1016/j.placenta.2010.12.003. No abstract available.

PMID:
21257078
38.

Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?

Cetin I, Huppertz B, Burton G, Cuckle H, Gonen R, Lapaire O, Mandia L, Nicolaides K, Redman C, Soothill P, Spencer K, Thilaganathan B, Williams D, Meiri H.

Placenta. 2011 Feb;32 Suppl:S4-16. doi: 10.1016/j.placenta.2010.11.022. Epub 2010 Dec 23.

PMID:
21185077
39.

Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants.

Grimpel YI, Kivity V, Cohen A, Meiri H, Sammar M, Gonen R, Huppertz B.

Placenta. 2011 Feb;32 Suppl:S55-64. doi: 10.1016/j.placenta.2010.11.019. Epub 2010 Dec 17.

PMID:
21168205
40.

The choriocarcinoma cell line BeWo: syncytial fusion and expression of syncytium-specific proteins.

Orendi K, Gauster M, Moser G, Meiri H, Huppertz B.

Reproduction. 2010 Nov;140(5):759-66. doi: 10.1530/REP-10-0221. Epub 2010 Aug 9.

PMID:
20696850
41.

Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar.

Várkonyi T, Nagy B, Füle T, Tarca AL, Karászi K, Schönléber J, Hupuczi P, Mihalik N, Kovalszky I, Rigó J Jr, Meiri H, Papp Z, Romero R, Than NG.

Placenta. 2011 Feb;32 Suppl:S21-9. doi: 10.1016/j.placenta.2010.04.014. Epub 2010 Jun 11.

42.

Effects of vitamins C and E, acetylsalicylic acid and heparin on fusion, beta-hCG and PP13 expression in BeWo cells.

Orendi K, Gauster M, Moser G, Meiri H, Huppertz B.

Placenta. 2010 May;31(5):431-8. doi: 10.1016/j.placenta.2010.02.017. Epub 2010 Mar 29.

PMID:
20347141
43.

First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk.

Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K.

Ultrasound Obstet Gynecol. 2010 Jun;35(6):671-9. doi: 10.1002/uog.7559.

44.

First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.

Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K.

Prenat Diagn. 2009 Aug;29(8):781-9. doi: 10.1002/pd.2287.

PMID:
19418482
45.

IFPA meeting 2008 workshops report.

Lash GE, Ansari T, Bischof P, Burton GJ, Chamley L, Crocker I, Dantzer V, Desoye G, Drewlo S, Fazleabas A, Jansson T, Keating S, Kliman HJ, Lang I, Mayhew T, Meiri H, Miller RK, Nelson DM, Pfarrer C, Roberts C, Sammar M, Sharma S, Shiverick K, Strunk D, Turner MA, Huppertz B.

Placenta. 2009 Mar;30 Suppl A:S4-14. doi: 10.1016/j.placenta.2008.11.014. Epub 2008 Dec 11.

46.

Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study.

Gonen R, Shahar R, Grimpel YI, Chefetz I, Sammar M, Meiri H, Gibor Y.

BJOG. 2008 Nov;115(12):1465-72. doi: 10.1111/j.1471-0528.2008.01902.x.

47.

Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome.

Than NG, Abdul Rahman O, Magenheim R, Nagy B, Fule T, Hargitai B, Sammar M, Hupuczi P, Tarca AL, Szabo G, Kovalszky I, Meiri H, Sziller I, Rigo J Jr, Romero R, Papp Z.

Virchows Arch. 2008 Oct;453(4):387-400. doi: 10.1007/s00428-008-0658-x. Epub 2008 Sep 13.

48.

Longitudinal determination of serum placental protein 13 during development of preeclampsia.

Huppertz B, Sammar M, Chefetz I, Neumaier-Wagner P, Bartz C, Meiri H.

Fetal Diagn Ther. 2008;24(3):230-6. doi: 10.1159/000151344. Epub 2008 Aug 28.

PMID:
18753763
49.

First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Romero R, Kusanovic JP, Than NG, Erez O, Gotsch F, Espinoza J, Edwin S, Chefetz I, Gomez R, Nien JK, Sammar M, Pineles B, Hassan SS, Meiri H, Tal Y, Kuhnreich I, Papp Z, Cuckle HS.

Am J Obstet Gynecol. 2008 Aug;199(2):122.e1-122.e11. doi: 10.1016/j.ajog.2008.01.013. Epub 2008 Jun 9.

50.

First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes.

Cowans NJ, Spencer K, Meiri H.

Prenat Diagn. 2008 Feb;28(2):121-5. doi: 10.1002/pd.1921.

PMID:
18186153

Supplemental Content

Support Center